Kinsie E. Arnst

948 total citations
15 papers, 751 citations indexed

About

Kinsie E. Arnst is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Kinsie E. Arnst has authored 15 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 9 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Kinsie E. Arnst's work include Synthesis and biological activity (9 papers), Cancer therapeutics and mechanisms (7 papers) and Cancer Mechanisms and Therapy (5 papers). Kinsie E. Arnst is often cited by papers focused on Synthesis and biological activity (9 papers), Cancer therapeutics and mechanisms (7 papers) and Cancer Mechanisms and Therapy (5 papers). Kinsie E. Arnst collaborates with scholars based in United States and China. Kinsie E. Arnst's co-authors include Wěi Li, Duane D. Miller, Hao Chen, Yuxi Wang, Zongtao Lin, Souvik Banerjee, Dong‐Jin Hwang, Shanshan Deng, Stephen W. White and Gyanendra Kumar and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and Journal of Controlled Release.

In The Last Decade

Kinsie E. Arnst

15 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kinsie E. Arnst United States 11 414 363 218 72 67 15 751
Konstantinos Kiakos United Kingdom 15 228 0.6× 523 1.4× 299 1.4× 68 0.9× 42 0.6× 43 890
Robert H. Gruninger United States 13 345 0.8× 252 0.7× 234 1.1× 44 0.6× 73 1.1× 14 704
Jeremy L. Yap United States 16 256 0.6× 727 2.0× 183 0.8× 33 0.5× 29 0.4× 22 867
Qinhuai Lai China 11 149 0.4× 226 0.6× 143 0.7× 50 0.7× 44 0.7× 18 455
Michał Sabisz Poland 14 180 0.4× 325 0.9× 156 0.7× 48 0.7× 23 0.3× 20 556
Pascal Furet Switzerland 7 189 0.5× 397 1.1× 247 1.1× 31 0.4× 41 0.6× 7 565
Marie‐Paule Hildebrand France 14 271 0.7× 336 0.9× 120 0.6× 17 0.2× 28 0.4× 17 630
Binbin Cheng China 15 184 0.4× 422 1.2× 404 1.9× 43 0.6× 28 0.4× 37 809
Xingzhi Tan United States 13 113 0.3× 486 1.3× 363 1.7× 132 1.8× 130 1.9× 20 815
Markella Konstantinidou Netherlands 12 250 0.6× 471 1.3× 279 1.3× 63 0.9× 21 0.3× 21 810

Countries citing papers authored by Kinsie E. Arnst

Since Specialization
Citations

This map shows the geographic impact of Kinsie E. Arnst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kinsie E. Arnst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kinsie E. Arnst more than expected).

Fields of papers citing papers by Kinsie E. Arnst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kinsie E. Arnst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kinsie E. Arnst. The network helps show where Kinsie E. Arnst may publish in the future.

Co-authorship network of co-authors of Kinsie E. Arnst

This figure shows the co-authorship network connecting the top 25 collaborators of Kinsie E. Arnst. A scholar is included among the top collaborators of Kinsie E. Arnst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kinsie E. Arnst. Kinsie E. Arnst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Banerjee, Souvik, Foyez Mahmud, Shanshan Deng, et al.. (2021). X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor. Journal of Medicinal Chemistry. 64(17). 13072–13095. 21 indexed citations
2.
Cui, Hongmei, Kinsie E. Arnst, Duane D. Miller, & Wěi Li. (2020). Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance. Current Medicinal Chemistry. 27(39). 6573–6595. 47 indexed citations
3.
Wang, Tao, Chengyong Wu, Chengdi Wang, et al.. (2020). Unraveling the molecular mechanism of BNC105, a phase II clinical trial vascular disrupting agent, provides insights into drug design. Biochemical and Biophysical Research Communications. 525(1). 148–154. 8 indexed citations
4.
Arnst, Kinsie E., Yuxi Wang, Zi‐Ning Lei, et al.. (2019). Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy. Molecular Pharmacology. 96(1). 73–89. 26 indexed citations
5.
Arnst, Kinsie E., Souvik Banerjee, Yuxi Wang, et al.. (2019). X-ray Crystal Structure Guided Discovery and Antitumor Efficacy of Dihydroquinoxalinone as Potent Tubulin Polymerization Inhibitors. ACS Chemical Biology. 14(12). 2810–2821. 17 indexed citations
6.
7.
Arnst, Kinsie E., Souvik Banerjee, Hao Chen, et al.. (2019). Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy. Medicinal Research Reviews. 39(4). 1398–1426. 118 indexed citations
8.
Wang, Qinghui, Kinsie E. Arnst, Yi Xue, et al.. (2018). Synthesis and biological evaluation of indole-based UC-112 analogs as potent and selective survivin inhibitors. European Journal of Medicinal Chemistry. 149. 211–224. 19 indexed citations
9.
Wang, Qinghui, Kinsie E. Arnst, Yuxi Wang, et al.. (2018). Structural Modification of the 3,4,5-Trimethoxyphenyl Moiety in the Tubulin Inhibitor VERU-111 Leads to Improved Antiproliferative Activities. Journal of Medicinal Chemistry. 61(17). 7877–7891. 48 indexed citations
10.
Banerjee, Souvik, Kinsie E. Arnst, Yuxi Wang, et al.. (2018). Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy. Journal of Medicinal Chemistry. 61(4). 1704–1718. 96 indexed citations
11.
Arnst, Kinsie E.. (2018). Abstract 3841: Biologic evaluation of heterocyclic pyrimidines as novel tubulin inhibitors targeting the colchicine binding site. Cancer Research. 78(13_Supplement). 3841–3841. 1 indexed citations
12.
Arnst, Kinsie E., Yuxi Wang, Dong‐Jin Hwang, et al.. (2017). A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance. Cancer Research. 78(1). 265–277. 100 indexed citations
13.
Chen, Hao, Zongtao Lin, Kinsie E. Arnst, Duane D. Miller, & Wěi Li. (2017). Tubulin Inhibitor-Based Antibody-Drug Conjugates for Cancer Therapy. Molecules. 22(8). 1281–1281. 168 indexed citations
14.
Yang, Ruinan, Goutam Mondal, Rachel A. Ness, et al.. (2017). Polymer conjugate of a microtubule destabilizer inhibits lung metastatic melanoma. Journal of Controlled Release. 249. 32–41. 9 indexed citations
15.
Arnst, Kinsie E., Dong‐Jin Hwang, Duane D. Miller, & Wei Li. (2017). Abstract 3223: Novel tubulin inhibitor DJ101 targets the colchicine binding site and suppresses melanoma growth and metastasis. Cancer Research. 77(13_Supplement). 3223–3223. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026